Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
Zacks.com on MSN1d
RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded UseUltragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
AquaSculpt is a natural weight loss supplement created by Dr. Blaine Schilling, a top New York City doctor specializing in weight loss. It's based on an "odd ice hack" theory that helps adults of all ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
The FDA has approved the first generic liraglutide indicated to improve glycemic control in adults and pediatric patients ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback